PERSPECTA

News from every angle

Back to headlines

Sangamo Aims for Fabry BLA Submission by Summer 2026, Advances Neurology Pipeline

Sangamo Therapeutics is targeting summer 2026 for its Fabry BLA submission while continuing to advance its neurology pipeline and engage in partner discussions.

30 Mar, 22:22 — 30 Mar, 22:22
PostShare

Sources

Showing 1 of 1 sources